Evidence map›Paper›PMID 19091783›Full record

ReviewBriefings in functional genomics & proteomics2009

Comparative glycoproteomics: approaches and applications.

Xin Wei, Lingjun Li

Open access · bronzeAbstract readReview
In one paragraph

Review in Briefings in functional genomics & proteomics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Chemical Glycoproteomics.Chemical reviews · 2016
    Review
  8. Glycoproteins and glycoproteomics in pancreatic cancer.World journal of gastroenterology · 2016
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Glycoproteomics-based identification of cancer biomarkers.International journal of proteomics · 2011
    Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xin WeiDepartment of Chemistry, University of Wisconsin, Madison, WI 53705-2222 USA.
Lingjun Li
University of Wisconsin–Madison · US

Funding

A Proteomic Approach to Biomarker Discovery in Prion DiseaseR21AI072588 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2007 to 2009
$380k
NIAID NIH HHS AI0272588NIAID NIH HHS R21 AI072588
6 · The paper itself

Abstract

Glycosylation plays fundamental roles in controlling various biological processes. Therefore, glycosylation analysis has become an important target for proteomic research and has great potential for clinical applications. With the continuous development and refinement of glycoprotein isolation methods, increasing attention has been directed to the quantitative and comparative aspects. This review describes the mass spectrometry (MS)-based techniques for the comparative analysis of glycoproteins and their applications to answer a wide range of interesting biological questions.

Indexed as

AnimalsBiomarkersCell Line, TumorChromatography, AffinityGene Expression ProfilingGlycoproteinsGlycosylationHumansLectinsMass SpectrometryNeoplasmsNeurodegenerative DiseasesProteomicsBiomarkersGlycoproteinsLectins

Identifiers

PMID19091783
PMCPMC2673949
OpenAlexW2163131666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.